Existence of Financial Equilibria in Continuous Time with Potentially Complete Markets

We prove that in smooth Markovian continuous-time economies with potentially complete asset markets, Radner equilibria with endogenously complete markets exist.Potentially complete market, Continuous-time financial market, Radner equilibrium, Itô diffusion, Analytic transition density

Exploratory Study of the Privacy Extension for System Theoretic Process Analysis (STPA-Priv) to elicit Privacy Risks in eHealth

Context: System Theoretic Process Analysis for Privacy (STPA-Priv) is a novel privacy risk elicitation method using a top down approach. It has not gotten very much attention but may offer a convenient structured approach and generation of additional artifacts compared to other methods. Aim: The aim of this exploratory study is to find out what benefits the privacy risk elicitation method STPA-Priv has and to explain how the method can be used. Method: Therefore we apply STPA-Priv to a real world health scenario that involves a smart glucose measurement device used by children. Different kinds of data from the smart device including location data should be shared with the parents, physicians, and urban planners. This makes it a sociotechnical system that offers adequate and complex privacy risks to be found. Results: We find out that STPA-Priv is a structured method for privacy analysis and finds complex privacy risks. The method is supported by a tool called XSTAMPP which makes the analysis and its results more profound. Additionally, we learn that an iterative application of the steps might be necessary to find more privacy risks when more information about the system is available later. Conclusions: STPA-Priv helps to identify complex privacy risks that are derived from sociotechnical interactions in a system. It also outputs privacy constraints that are to be enforced by the system to ensure privacy.Comment: author's post-prin

Applicability analysis: elicitation of privacy risks through STPA(-Priv) in a selected IoT-scenario

Context This bachelor’s thesis discusses the usage of System-Theoretic Process Analysis (STPA) for privacy engineering. STPA has been developed for safety engineering originally. I show how this methodology can be applied to privacy risk analysis by using the extension STPA-Priv. I explain why privacy is important and why privacy risk analysis can help improve systems regarding privacy. Objective The goal is to apply the privacy extension of STPA to a real-world Internet of Things scenario to determine the applicability and possible problems with this methodology. Method STPA considers safety a system property. I think that privacy is a system property as well and therefore STPA can be applied to privacy risk analysis. Most changes from STPA to STPA-Priv have been made in its terminology, the process itself remains the same. This brings many of the advantages of systems theory to the field of privacy engineering, such as the top-down nature of STPA that helps handle complex socio-technical systems. Results I found out that STPA-Priv is a good approach to elicit privacy risks and requirements. I was able to elicit many privacy risks from our scenario using STPA-Priv which shows that the methodology works in general. Conclusions After all, I can recommend using STPA-Priv to evaluate projects for privacy risks. Nevertheless, there are still changes and improvements necessary. However, the overall methodology would not be affected by those changes. STPA-Priv is very straight-forward for people that are already familiar with STPA

Existence of financial equilibria in continuous time with potentially complete markets

Riedel F, Herzberg F. Existence of financial equilibria in continuous time with potentially complete markets. Working Papers. Institute of Mathematical Economics. Vol 443. Bielefeld: Center for Mathematical Economics; 2010.We prove that in smooth Markovian continuous{time economies with potentially complete asset markets, Radner equilibria with endoge- nously complete markets exist

Vascular Response on a Novel Fibrin-Based Coated Flow Diverter

Purpose Due to thromboembolic complications and in-stent-stenosis after flow diverter (FD) treatment, the long-term use of dual antiplatelet treatment (DAPT) is mandatory. The tested nano-coating has been shown to reduce material thrombogenicity and promote endothelial cell proliferation in vitro. We compared the biocompatibility of coated (Derivo Heal) and non-coated (Derivo bare) FDs with DAPT in an animal model. Methods Derivo® bare (n = 10) and Derivo® Heal (n = 10) FD were implanted in the common carotid arteries (CCAs) of New Zealand white rabbits. One additional FD, alternately a Derivo bare (n = 5) or Derivo Heal (n = 5), was implanted in the abdominal aorta (AA) for assessment of the patency of branch arteries. Histopathological examinations were performed after 28 days. Angiography was performed before and after FD implantation and at follow-up. Results Statistical analysis of the included specimens showed complete endothelialization of all FDs with no significant differences in neointima thickness between Derivo® bare and Derivo® Heal (CCA: p = 0.91; AA: p = 0.59). A significantly reduced number of macrophages in the vessel wall of the Derivo Heal was observed for the CCA (p = 0.02), and significantly reduced fibrin and platelet deposition on the surface of the Derivo Heal was observed for the AA. All branch arteries of the stented aorta remained patent. Conclusion In this animal model, the novel fibrin-based coated FD showed a similar blood and tissue compatibility as the non-coated FD

Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study

Background: In Germany, most breast cancer patients are treated in specialized breast cancer units (BCU), which are certified, and routinely monitored. Herein, we evaluate up-to-date oncological outcome of breast cancer (BC) molecular subtypes in routine clinical care of a specialized BCU. Methods: The study was a prospectively single-center cohort study of 4102 female cases with primary, unilateral, non-metastatic breast cancer treated between 01 January 2003 and 31 December 2012. The five routinely used molecular subtypes (Luminal A-like, Luminal B/HER2 negative-like, Luminal B/HER2 positive-like, HER2-type, Triple negative) were analyzed. The median follow-up time of the whole cohort was 55 months. We calculated estimates for local control rate (LCR), disease-free survival (DFS), distant disease-free survival (DDFS), overall survival (OS), and relative overall survival (ROS). Results: Luminal A-like tumors were the most frequent (44.7%) and showed the best outcome with LCR of 99.1% (95% CI 98.5; 99.7), OS of 95.1% (95% CI 93.7; 96.5), and ROS of 100.0% (95% CI 98.5; 101.5). Triple negative tumors (12.3%) presented the poorest outcome with LCR of 89.6% (95% CI 85.8; 93.4), OS of 78.5% (95% CI 73.8; 83.3), and ROS of 80.1% (95% CI 73.8; 83.2). Conclusions: Patients with a favorable subtype can expect an OS above 95% and an LCR of almost 100% over 5 years. On the other hand the outcome of patients with HER2 and Triple negative subtypes remains poor, thus necessitating more intensified research and care